Noxisense

Company Name
Noxisense SAS
Main Vertical
HealthTech
CEO/FOUNDER
Name and Surname
Jose Biurrun Manresa
Linkedin Profile or Bio
Name and Surname
Silvio Laugero
Name and Surname
Leandro Mayrata
Linkedin Profile or Bio
Number of people on the Staff
4
Legal Form
Simplified Joint Stock Company (SAS)
Year of Founding
2024
Type of Company
Startup
Development Stage
Validation
Province
Entre Ríos
City
Oro Verde
Main Business Model
B2B
Problem
The main problem is that measuring pain remains subjective: doctors rely on what the patient reports, which often doesn't accurately reflect the severity of the damage. In people with diabetes, this is especially critical, as up to 50% develop diabetic neuropathy, a condition that damages nerves and can cause severe pain or loss of sensation. If not detected early, it can lead to ulcers, infections, and, in many cases, amputations. Current tools for diagnosing this condition are invasive, expensive, or poorly accessible, which delays treatment and worsens outcomes.
Solutions Offered - Summary
Portable, objective diagnostic for neuropathic pain
Solutions Offered - Details
Noxisense develops a portable medical device for objective and non-invasive diagnosis of neuropathic pain. Using radiofrequency stimulation and EEG analysis, it assesses small nerve fiber function, providing healthcare professionals with an accurate, accessible, and quantitative tool to improve diagnosis, treatment decisions, and patient outcomes.
Technologies Used
Machine or Deep Learning, Other
Counterparties of Interest abroad
Accelerator, Financing, Incubators, Soft Landing, Users, Validation
Industries served
Hospitals, Medical Equipment, Pharmaceutical
International Presence
GERMANY, BELGIUM, DENMARK
Investment Round:
Bootstrapping
E-mail
leandromayrata@gmail.com